Robert Whitfield MDAmerica's Breast Implant Illness Expert™

Unlocking Gut Health's Role in Breast Implant Recovery

2 Dec 2024 · 1 min

Watch on YouTube

0:57

Robert Whitfield MD (speaker) discusses clinical experience treating breast implant illness, focusing on how removing immune triggers via explantation often improves symptoms. He notes that about two thirds of patients are not infected, and that a recently published paper of his reports roughly one third of patients have a bacterial contaminant detected by PCR testing. The segment links explant outcomes to presence/absence of infection or device rupture and emphasizes variability in recovery.

Questions this video answers

About two thirds of the patients are not infected.

Roughly a third of patients had a bacterial contaminant detected on PCR testing.

Chapters

I think you mentioned, oh, there's so many good points in that. So we look at gut health. You know, I feel that is probably when I first started taking care of patients with breast implant illness, and I didn't quite understand the variance or the variability in outcome. So I would do an explant. If someone had an infection, they would do well. If someone had a ruptured device and I got all the material out, they would do well. So in those instances, those are crude examples of we remove a big trigger to the immune system and then they start, you know, doing better, quote, unquote. I'll just say globally they would do better. But in those patients that weren't infected, we'll say about two thirds of the patients aren't. I recently published a paper, and it talks about roughly a third have a bacterial contaminant that's found on PCR testing.